iGMDRD134
| Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
|---|---|---|---|---|---|---|---|
| Sorafenib | CHEMBL1760433 CHEMBL1200485 CHEMBL1336 | 216239 | D08524 | DB00398 | Alone | DAP000006 | Small Molecule |
Drug Class:
Acids, HeterocyclicAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsBCRP/ABCG2 InhibitorsBCRP/ABCG2 SubstratesBenzene DerivativesCytochrome P-450 CYP2C9 InhibitorsCytochrome P-450 CYP2C9 Inhibitors (weak)Cytochrome P-450 Enzyme InhibitorsEnzyme InhibitorsHeterocyclic CompoundsHeterocyclic Compounds, 1-RingHydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicImmunosuppressive AgentsKinase InhibitorMiscellaneous Therapeutic AgentsMyelosuppressive AgentsNicotinic AcidsP-glycoprotein/ABCB1 InhibitorsP-glycoprotein/ABCB1 SubstratesPotential QTc-Prolonging AgentsProtein Kinase InhibitorsPyridinesQTc Prolonging Agentsraf KinasesReceptors, Vascular Endothelial Growth FactorUGT1A1 InhibitorsUreaVascular Endothelial Growth Factor Receptor 2 AntagonistDrug Targets:
BRAF (P15056)RAF1 (P04049)VEGFRFLT4 (P35916)KDR (P35968)FLT3 (P36888)PDGFRB (P09619)KIT (P10721)FGFR1 (P11362)RET (P07949)FLT1 (P17948)Drug Pathways:
RTK signalingMAPK signaling pathwayErbB signaling pathwayVEGF signaling pathwayPathways in cancerRenal cell carcinomaThyroid cancerHepatocellular carcinomaDrug Synonyms:
Sorafenib (USAN/INN)Drug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
| Gene ID | Gene Name | Model Num. |
|---|---|---|
| 259173 | ALS2CL | 2 |
| 8690 | JRKL | 1 |
| 4646 | MYO6 | 1 |
| 64761 | PARP12 | 1 |
| 9791 | PTDSS1 | 1 |
| 6189 | RPS3A | 1 |
| 3845 | KRAS | 5 |
| 80017 | DGLUCY | 1 |
| 8573 | CASK | 1 |
| 6597 | SMARCA4 | 1 |
| 11160 | ERLIN2 | 2 |
| 57169 | ZNFX1 | 1 |
| 285489 | DOK7 | 1 |
| 4771 | NF2 | 1 |
| 858 | CAV2 | 2 |
| 56937 | PMEPA1 | 1 |
| 25960 | ADGRA2 | 1 |
| 3934 | LCN2 | 1 |
| 642799 | NPIPA2 | 2 |
| 647024 | C6orf132 | 2 |
| 5159 | PDGFRB | 1 |
| 4851 | NOTCH1 | 1 |
| 55294 | FBXW7 | 1 |
| 7307 | U2AF1 | 1 |
| 3437 | IFIT3 | 2 |
| 6282 | S100A11 | 1 |
| 4610 | MYCL | 1 |
| 4300 | MLLT3 | 1 |
| 6156 | RPL30 | 1 |
| 9052 | GPRC5A | 2 |
| 7428 | VHL | 1 |
| 2064 | ERBB2 | 1 |
| 54467 | ANKIB1 | 1 |
| 6037 | RNASE3 | 3 |
| 1523 | CUX1 | 1 |
| 23401 | FRAT2 | 2 |
| 148327 | CREB3L4 | 1 |
| 80301 | PLEKHO2 | 1 |
| 54809 | SAMD9 | 2 |
| 1029 | CDKN2A | 2 |
| 7157 | TP53 | 2 |
| 6794 | STK11 | 1 |
| 2322 | FLT3 | 22 |
| 3791 | KDR | 3 |
| 4292 | MLH1 | 1 |
| 64129 | TINAGL1 | 2 |
| 4086 | SMAD1 | 1 |
| 7422 | VEGFA | 1 |
| 369 | ARAF | 8 |
| 8796 | SCEL | 1 |
| 3433 | IFIT2 | 2 |
| 116447 | TOP1MT | 1 |
| 4089 | SMAD4 | 1 |
| 56997 | COQ8A | 1 |
| 8731 | RNMT | 2 |
| 5290 | PIK3CA | 1 |
| 2202 | EFEMP1 | 1 |
| 6277 | S100A6 | 1 |
| 11212 | PLPBP | 2 |
| 4609 | MYC | 1 |
| 7328 | UBE2H | 1 |
| 6122 | RPL3 | 1 |
| 283358 | B4GALNT3 | 1 |
| 1031 | CDKN2C | 1 |
| 5156 | PDGFRA | 1 |
| 673 | BRAF | 9 |
| 6129 | RPL7 | 1 |
| 406956 | MIR181B2 | 1 |
| 170463 | SSBP4 | 1 |
| 5979 | RET | 1 |
| 9367 | RAB9A | 1 |
| 7286 | TUFT1 | 1 |
| 55290 | BRF2 | 1 |
| 5728 | PTEN | 1 |
| 3675 | ITGA3 | 2 |
| 4736 | RPL10A | 1 |
| 359845 | RFLNB | 2 |
| 79571 | GCC1 | 2 |
| 440021 | KRTAP5-2 | 1 |
| 57707 | TLDC1 | 1 |
| 7057 | THBS1 | 1 |
| 78991 | PCYOX1L | 1 |
| 140680 | C20orf96 | 1 |
| 6083 | SNORD21 | 1 |
| 3096 | HIVEP1 | 1 |
| 90102 | PHLDB2 | 1 |
| 8842 | PROM1 | 1 |
| 330 | BIRC3 | 2 |
| 3815 | KIT | 51 |
| 132299 | OCIAD2 | 2 |
| 5925 | RB1 | 1 |
| 4893 | NRAS | 4 |
| 3691 | ITGB4 | 1 |
| 7403 | KDM6A | 1 |
| 100873312 | RNA5SP78 | 1 |
| 59277 | NTN4 | 2 |
| 57153 | SLC44A2 | 2 |
| 595 | CCND1 | 2 |
| 4763 | NF1 | 3 |
| 4613 | MYCN | 1 |
| 5493 | PPL | 1 |
| 83871 | RAB34 | 1 |
| 2178 | FANCE | 2 |
| 1499 | CTNNB1 | 1 |
| 3162 | HMOX1 | 1 |
| 257397 | TAB3 | 1 |
| 5624 | PROC | 1 |
| 79872 | CBLL1 | 1 |
Gene in drug-gene network: Network Plot
Models in Sorafenib

